Barrow, Hanley, Mewhinney & Strauss
CLB icon

Barrow, Hanley, Mewhinney & Strauss’s Core Laboratories CLB Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.42K Hold
323
– – ﹤0.01% 263
2025
Q4 		$5.18K Hold
323
– – ﹤0.01% 269
2025
Q3 		$3.99K Hold
323
– – ﹤0.01% 289
2025
Q2 		$3.72K Hold
323
– – ﹤0.01% 271
2025
Q1 		$4.84K Hold
323
– – ﹤0.01% 256
2024
Q4 		$5.59K Hold
323
– – ﹤0.01% 265
2024
Q3 		$5.99K Hold
323
– – ﹤0.01% 260
2024
Q2 		$6.55K Buy
323
+147
+84% +$2.6K ﹤0.01% 228
2024
Q1 		$3.01K Hold
176
– – ﹤0.01% 254
2023
Q4 		$3.11K Buy
176
+90
+105% +$1.81K ﹤0.01% 254
2023
Q3 		$2.06K Buy
+86
New +$2.11K ﹤0.01% 272

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's CLB Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its Core Laboratories (CLB) position steady in Q1 2026 at 323 shares worth $5.42K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CLB in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.55K in Q2 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 323 shares of Core Laboratories worth $5.42K as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its Core Laboratories share count unchanged in Q1 2026.
  • Core Laboratories made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #263 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Core Laboratories in Q3 2023 and has held it in 11 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Core Laboratories position peaked at $6.55K in Q2 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.